Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Achieve Life Sciences Inc ACHV

Healthcare Biotechnology
Achieve Life Sciences, Inc. is a late-stage clinical pharmaceutical company. The Company is engaged in development and commercialization of cytisinicline for smoking cessation and nicotine addiction. The Company’s product candidate, cytisinicline, is a naturally occurring, plant-based alkaloid. Cytisinicline is structurally similar to nicotine and has a well-defined, dual-acting mechanism of... see more

Recent & Breaking News (NDAQ:ACHV)

Achieve Reports Financial Results for Third Quarter 2017

PR Newswire November 9, 2017

Achieve to Present at the 29th Annual Piper Jaffray Healthcare Conference on November 28th, 2017

PR Newswire November 8, 2017

Achieve Announces Availability of Company Presentation from the Virtual Investor Conference

PR Newswire November 6, 2017

Live Investor Conference & Webinar: NASDAQ, NYSE and OTC companies present November 2nd

PR Newswire October 30, 2017

Achieve Announces Company Presentation at Virtual Investor Conference on November 2, 2017

PR Newswire October 30, 2017

Mid-Afternoon Market Update: Buffalo Wild Wings Rises On Upbeat Earnings; Atossa Genetics Shares Plummet

Benzinga.com  October 26, 2017

Mid-Day Market Update: Essendant Drops After Q3 Results; Achieve Life Sciences Shares Climb

Benzinga.com  October 26, 2017

Mid-Morning Market Update: Markets Open Higher; Twitter Beats Q3 Estimates

Benzinga.com  October 26, 2017

Achieve Announces Exclusive, Long-term Manufacturing Agreement with Sopharma for Clinical and Commercial Supply of Cytisine

PR Newswire October 26, 2017

Achieve Announces Advancement of Cytisine Clinical Development Program

PR Newswire October 4, 2017

Achieve Announces Share Purchase Agreement with Lincoln Park Capital Fund, LLC

PR Newswire September 14, 2017

Achieve Announces Initiation of Cytisine Clinical Development Program

PR Newswire August 16, 2017